Sales and Marketing

Showing 15 posts of 11520 posts found.

online_feature_image

New Year, new goals

February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer Research UK, Chiesi, EMA, FDA, Genetic Alliance, pharma

With the New Year begun in earnest, Pharmafocus speaks to a range of players in pharma and the life sciences …
facilities_lg06

Dr Reddy’s hit by yet another recall, of 80,000+ bottles

February 8, 2018 Sales and Marketing Dr Reddy's, FDA, biotech, drugs, pharma, pharmaceutical

Dr Reddy’s Laboratories problem with ensuring products reach the market at a quality the FDA deems acceptable is no secret …
gilead-sciences

FDA approves Gilead’s Biktarvy for HIV as Viiv Healthcare launches patent lawsuit

February 8, 2018 Sales and Marketing Biktarvy, FDA, GSK, Gilead, HIV, Pfizer, Shionogi, US, ViiV Healthcare, descovy, pharma

Gilead has announced that its daily single-tablet therapy Biktarvy has received FDA approval for HIV-1 infection.
novartis_window

Novartis tastes own medicine, Advair generic delayed

February 8, 2018 Sales and Marketing FDA, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis had not been frontrunner to receive approval for its generic version of GSK’s Advair – lagging behind Mylan’s generic …

Theravance seals potential $1bn deal with J&J

February 8, 2018 Sales and Marketing Johnson & Johnson, Theravance Biopharma, biotech, drugs, pharma, pharmaceutical

The JAK inhibitor field is beginning to heat up – AbbVie is soon to enter Phase 3 with its predicted …
kenji

Astellas confirms Kenji Yasukawa as new President and CEO

February 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, appointment

Japanese pharmaceutical firm Astellas has announced that its Board of Directors has approved the selection of current Chief Strategy Officer …
arcturus_joseph-e-payne

CEO gets the axe: Arcturus relieve Payne of position

February 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arcturus, biotech, drugs, pharma, pharmaceutical

Early in February, Arcturus Therapeutics revealed that it had let its CEO, Joseph Payne, go and had replaced him as …
allergan

Allergan bolsters skincare portfolio with Elastagen acquisition for $95 million

February 7, 2018 Research and Development, Sales and Marketing Allergan, Elastagen, M&A, MA, pharma

Pharma’s M&A train keeps on going as news breaks that Allergan has picked up University of Sydney spin-off Elastagen for …
mark_walsh_allergan

Allergan successfully concludes CFO search

February 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

Allergan has been searching for a new Chief Financial Officer since Tessa Hilado, its current CFO, revealed that she would …
radio-active-2003201_960_720

PTx picks up radiation drug and plant from Sanofi

February 6, 2018 Manufacturing and Production, Sales and Marketing Partnership Therapeutics, Sanofi, biotech, drugs, pharma, pharmaceutical

A Boston-based biotech, only a few weeks old, has moved quickly to secure both the drug Leukine and the plant …
ai_graphic

The future is now: The transformative power of AI

February 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Exscientia, GSK, GlaxoSmithKline, artificial intelligence, drug development, pharma

With the technologies reaching exciting levels of maturity and adoption, Matt Fellows investigates how AI and machine learning can be …
nektar-therapeutics

Rapidly-growing Nektar Therapeutics reportedly considering sale of its business

February 5, 2018 Manufacturing and Production, Sales and Marketing M&A, MA, Nektar, Nektar Therapeutics, acquisition, pharma

After a slew of M&A deals throughout the first month of 2018, including Celgene’s buyout of Juno Therapeutics for $9 …
shutterstock_158366573

UK GPs are “undervalued” with 40% looking to quit profession, study finds

February 5, 2018 Medical Communications, Sales and Marketing GPs, NHS, UK, health, pharma

Falling numbers of General Practitioners (GPs) in the UK are due to “concerns regarding professional risk in delivering care in …
pink_ribbon

UK breast cancer mortality falls 10% over five years, overtaken by prostate deaths for first time

February 5, 2018 Research and Development, Sales and Marketing Cancer, Cancer Research UK, breast cancer, pharma, prostate cancer

Breast cancer deaths in the UK have fallen by 10% in the past five years, according to research released by …

Philippines’ launches legal action after Sanofi refuses to refund over dengue vaccine damages

February 5, 2018 Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

Sanofi has refused both requests from the Government of the Philippines to refund used doses of its Dengvaxia vaccine as …
The Gateway to Local Adoption Series

Latest content